Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Intermittent Claudication by G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells

NCT03683628 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT03683628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03683628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Intermittent Claudication by G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells
Lead sponsor
Mahidol University
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2018
Completion date
December 31, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic ischemic disease, intermittent claudication, pad